Thermo Fisher Scientific Completes Acquisition of Life Technologies - - Chromatography Online
Thermo Fisher Scientific Completes Acquisition of Life Technologies

LCGC Europe eNews

Thermo Fisher Scientific (California, USA) has completed its acquisition of Life Technologies Corporation for $13.6 billion, following receipt of all required regulatory approval. Thermo Fisher has now established a new segment, Life Science Solutions that will be headed by Mark Stevenson, who served as CEO of Life Technologies.

The completion of the acquisition follows an earlier announced sale of Thermo Fisher’s cell culture, gene modulation, and magnetic beads business to GE Healthcare for $1.06 billion. As of 1 January 2014, the company’s financial performance will be reported in four segments:

• The new Life Sciences Solutions Segment will consist of the majority of the former Life Technologies and Thermo Fisher Biosciences businesses.
• Thermo Fisher’s Global Chemicals business will move from the Biosciences business to the Laboratory Products and Services Segment.
• Thermo Fisher’s Analytical Technologies Segment will be renamed Analytical Instruments to reflect the transfer of the Biosciences businesses to other segments, as mentioned above.
• Two small specialty diagnostics businesses within Life Technologies will become part of the Specialty Diagnostics Segment.

Marc N. Casper, President and CEO of Thermo Fisher Scientific, said: “We are pleased to announce that this transaction is now complete, and excited about our opportunity to create unrivalled leadership in serving research, life sciences, specialty diagnostics and applied markets.” He added: “Our combined offering provides cutting-edge technologies, such as genomics and proteomics, to accelerate life sciences research and improve human health. And our complementary strengths in biosciences and bioprocessing will accelerate drug discovery, development, and production. With the addition of Life Technologies, we are in an even stronger position to help our customers achieve their goals for innovation and productivity.”

For more information visit: www.thermofisher.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Sample Prep Perspectives | Ronald E. Majors: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments.
LATEST: UV Detector Problems


Perspectives in Modern HPLC | Michael W. Dong: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: Superficially Porous Particles: Perspectives, Practices, and Trends


MS — The Practical Art | Kate Yu: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting | John Dolan: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: Problems with Large-Molecule Separations


More LCGC Chromatography-Related Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: LCGC Europe eNews,
Click here